Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

41.71
-0.8200-1.93%
Post-market: 41.860.1507+0.36%17:55 EDT
Volume:11.64M
Turnover:488.62M
Market Cap:186.24B
PE:10.42
High:42.72
Open:42.47
Low:41.47
Close:42.53
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.39
T/O Rate:0.37%
Dividend:1.72
Dividend Rate:4.13%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.72
PE(LYR):11.52

Loading ...

Novo Nordisk A/S Stock (NVO) Closed Down by 3.09% on Sep 8: Facts Behind the Movement

TradingKey
·
Sep 09

Movement Alert|Novo-Nordisk A/S Falls 3.08% in Regular Trading, Two Late-Stage Ziltivekimab Trials Halted as Pipeline Suffers Setback

Market Focus
·
Sep 09

GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could be Another Huge Market.

Dow Jones
·
Sep 09

Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs

MT Newswires Live
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug

MT Newswires Live
·
Sep 08

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live
·
Sep 08

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement
·
Sep 08

Novo Nordisk (0QIU) Receives a Hold from Barclays

TIPRANKS
·
Sep 08

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

TIPRANKS
·
Sep 08

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg
·
Sep 08

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

TIPRANKS
·
Sep 08

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

TIPRANKS
·
Sep 08

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Dow Jones
·
Sep 08

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

TIPRANKS
·
Sep 07

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Reuters
·
Sep 07

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

TIPRANKS
·
Sep 07

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

TIPRANKS
·
Sep 05

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Movement Alert|Novo-Nordisk A/S Falls 3.01% in Regular Trading, Next-Gen Weight-Loss Drug Trial Results Trail Eli Lilly Zepbound

Market Focus
·
Sep 04